Received Apr 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | 47N3Y | — |
Maladministration of Shingrix after a temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a 50-year-old male patient who received Herpes zoster (Shingrix) (batch number 47N3Y, expiry date 20-MAR-2027) for prophylaxis. On 22-APR-2025, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incorrect storage of drug (Verbatim: Maladministration of Shingrix after a temperature excursion). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK Receipt Date: 24-APR-2025 The Shingrix was exposed to -8C for 6 hours on 22nd April 2025. After this temperature excursion, Shingrix was administered to a patient, which led to incorrect storage of drug. The reporter consented to follow up.